Free Trial
NASDAQ:CDLX

Cardlytics (CDLX) Stock Price, News & Analysis

Cardlytics logo
$1.18 -0.12 (-9.23%)
Closing price 04:00 PM Eastern
Extended Trading
$1.23 +0.05 (+3.90%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cardlytics Stock (NASDAQ:CDLX)

Key Stats

Today's Range
$1.17
$1.31
50-Day Range
$1.30
$3.12
52-Week Range
$1.17
$5.25
Volume
2.00 million shs
Average Volume
1.18 million shs
Market Capitalization
$61.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.25
Consensus Rating
Hold

Company Overview

Cardlytics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

CDLX MarketRank™: 

Cardlytics scored higher than 71% of companies evaluated by MarketBeat, and ranked 98th out of 306 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Cardlytics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cardlytics' stock forecast and price target.
  • Earnings Growth

    Earnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardlytics is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardlytics is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cardlytics has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    12.23% of the outstanding shares of Cardlytics have been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 5.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 13.71%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cardlytics does not currently pay a dividend.

  • Dividend Growth

    Cardlytics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.23% of the outstanding shares of Cardlytics have been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 5.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 13.71%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cardlytics has a news sentiment score of -0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Cardlytics this week, compared to 5 articles on an average week.
  • Search Interest

    Only 4 people have searched for CDLX on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,390.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Cardlytics is held by insiders.

  • Percentage Held by Institutions

    68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardlytics' insider trading history.
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

CDLX Stock News Headlines

Cardlytics (CDLX) Q2 Users Jump 19%
Cardlytics Reports Q2 2025 Financial Results
How high will gold surge?
Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold … and reveals a little-known way to get ahead of this bull market.
Cardlytics, Inc. (CDLX) Q2 2025 Earnings Call Transcript
Cardlytics Announces Second Quarter 2025 Financial Results
See More Headlines

CDLX Stock Analysis - Frequently Asked Questions

Cardlytics' stock was trading at $3.71 at the start of the year. Since then, CDLX shares have decreased by 68.2% and is now trading at $1.18.

Cardlytics, Inc. (NASDAQ:CDLX) issued its quarterly earnings data on Wednesday, August, 6th. The company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The business had revenue of $63.25 million for the quarter, compared to analysts' expectations of $64.06 million. Cardlytics had a negative net margin of 68.87% and a negative trailing twelve-month return on equity of 269.90%.
Read the conference call transcript
.

Cardlytics subsidiaries include Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

Cardlytics (CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics' top institutional investors include Lane Generational LLC (1.49%), Geode Capital Management LLC (1.20%), Acorn Financial Advisory Services Inc. ADV (0.62%) and Wolverine Asset Management LLC. Insiders that own company stock include Clifford Sosin, Karim Saad Temsamani, Amit Gupta, Scott D Grimes, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen and John V Balen.
View institutional ownership trends
.

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

Last Earnings
8/06/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Services
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CDLX
CIK
1666071
Fax
N/A
Employees
500
Year Founded
2008

Price Target and Rating

High Price Target
$5.00
Low Price Target
$2.00
Potential Upside/Downside
+175.4%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$189.30 million
Net Margins
-68.87%
Pretax Margin
-65.41%
Return on Equity
-269.90%
Return on Assets
-47.37%

Debt

Debt-to-Equity Ratio
2.62
Current Ratio
1.19
Quick Ratio
1.19

Sales & Book Value

Annual Sales
$278.30 million
Price / Sales
0.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.38 per share
Price / Book
0.86

Miscellaneous

Outstanding Shares
52,500,000
Free Float
50,192,000
Market Cap
$61.95 million
Optionable
Optionable
Beta
1.26

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CDLX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners